Mayo Clinic
genomic foundation model
This revolutionary model is designed to improve diagnostics and personalize treatment selection, starting with progress in Rheumatoid Arthritis treatment.
Outperforms today's best models
The genomic model was trained on the Cerebras Wafer Scale Cluster in the Cerebras cloud. The results were achieved by combining publicly available human reference genome data with Mayo's comprehensive patient exome data.
1 Billion Parameters
10x larger than AlphaFold
1 Trillion Tokens
Leveraging Mayo’s in-house patient data
"Mayo is committed to fundamentally transforming healthcare by using the most advanced AI technology. We’ve been able to develop AI tools with such promise in less than a year, in part, because of our collaboration with Cerebras that enabled us to create this state-of-the-art AI model for genomics."
Matthew Callstrom, MD, PhD
Medical Director for Strategy, Chair - Dept. of Radiology
"It is an honor to collaborate with Mayo Clinic, the top-ranked hospital in the nation. With its recognized leadership in delivering medical outcomes, we are uniquely positioned to combine AI and medicine. The state-of-the-art AI models we are developing together will work alongside doctors to help with patient diagnosis, treatment planning, and outcome estimation."
Andrew Feldman
CEO and co-founder, Cerebras
This new state-of-the-art foundation model for genomics achieves unprecedented accuracy in disease prediction.
96%
Accuracy in Cancer Predisposing
83%
Accuracy in Cardiovascular Predisposing
87%
Accuracy in Drug Response for Rheumatoid Arthritis
